<DOC>
	<DOCNO>NCT00527059</DOCNO>
	<brief_summary>The purpose study evaluate effect levosimendan infusion , addition standard therapy , renal function patient Acute Heart Failure , compare standard therapy alone .</brief_summary>
	<brief_title>Renal Effects Levosimendan Patients Admitted With Acute Decompensated Heart Failure</brief_title>
	<detailed_description>The term `` cardiorenal syndrome '' apply presence development renal dysfunction HF patient may major precipitant decompensation cause admission patient . The renal hypoperfusion occur cardiac injury lead sodium water retention activation renin-angiotensin-aldosterone system neurohormonal pathway resultant deleterious effect myocardium . A vicious cycle may ensue associate increased cardiovascular complication . In regard , renal dysfunction functional nature thus mean intervene vicious cycle need seek . Several study already demonstrate deleterious effect renal dysfunction prognosis patient HF due chronic leave ventricular dysfunction . Levosimendan increase myocardial contractility without significant change intracellular calcium ion cyclic adenosine monophosphate concentration enhance myocardial oxygen demand . By action potassium channel drug also dilate coronary peripheral artery exert anti-ischemic , anti-stunning effect . To date , effect levosimendan renal function patient worsen chronic HF , remain unknown .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<mesh_term>Simendan</mesh_term>
	<criteria>ejection fraction ( EF ) 40 % transthoracic echocardiogram , baseline pulmonary capillary wedge pressure ( PCWP ) 20 mm Hg MDRD ( Modification Diet Renal Disease ) score &gt; 30 &lt; 60 standard therapy HF include angiotensin convert enzyme inhibitor , angiotensin receptor blocker , aldosterone block agent ( spironolactone ) betablockers , unless contraindicate patient receive oral i.v . inotropes , oral i.v . diuretic receive nitroglycerine nitroprusside , patient systolic blood pressure &lt; 110 mmHg , mechanical ventilation , anticipated survival &lt; 30 day , absence thoracic windows echocardiography , acute coronary syndrome , sustain ventricular tachycardia ventricular fibrillation , document renal artery stenosis , require dialysis , require admission primarily concurrent morbidity , severe aortic mitral regurgitation , leave ventricular failure primarily uncorrected obstructive valvular disease , hypertrophic obstructive cardiomyopathy , restrictive/obstructive cardiomyopathy , uncorrected thyroid disease , know amyloid cardiomyopathy know malfunction artificial heart valve .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>Cardiorenal syndrome</keyword>
</DOC>